CKS1B and plasma cell myeloma: Firstly, significant upregulation of CKS1B protein and mRNA level in OS was demonstrated, which is consistent with the findings of highly expressed CKS1B in nasopharyngeal, breast cancer, non-small-cell lung cancer, Burkitt lymphoma, and multiple myeloma [60–63].